Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
Beta Bionics (Nasdaq: BBNX) announced management will present at the TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 10:30 am ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Beta Bionics (Nasdaq: BBNX) announced management will present at the TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 10:30 am ET. A live audio webcast will be available on the company’s investor site and archived for later replay.
Details
News Market Reaction – BBNX
On Feb 20, the first trading day after this news, BBNX closed 1.78% above the previous close.
Data tracked by StockTitan Argus for the Feb 20 session.
Key Figures
- Conference date
- March 4, 2026
- TD Cowen 46th Annual Health Care Conference presentation date
- Presentation time ET
- 10:30 am Eastern Time
- Scheduled time for management presentation
- Presentation time PT
- 7:30 am Pacific Time
- Local Pacific Time for presentation
- Price move
- -5.51%
- BBNX price change over the prior 24 hours before this news
- 52-week high
- $32.71
- Pre-news 52-week high for BBNX
- 52-week low
- $8.89
- Pre-news 52-week low for BBNX
- Market cap
- $599,175,228
- Pre-news market capitalization
- 200-day MA
- 20.22
- Pre-news 200-day moving average level
Historical Context
-
Reported strong 2025 growth and issued 2026 revenue and margin guidance.
-
Released preliminary Q4 2025 topline results with strong sales growth metrics.
-
Announced plan to pre-release Q4 2025 topline results and meet investors.
-
Outlined participation in Wolfe Research and Piper Sandler healthcare conferences.
-
Reported strong Q3 2025 growth, higher guidance, and improved gross margin.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
IRVINE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at TD Cowen’s 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 10:30 am Eastern Time (7:30 am Pacific Time).
A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the event.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.